Furthermore, the GEPIA database6 indicated that MAGI2-AS3 was poorly-expressed in esophageal cancer (Figure 4D), and subsequent determination of MAGI2-AS3 levels in esophageal cancer and adjacent normal tissues confirmed that result (Figure 4E). Here, PDS5B is linked to esophageal cancer.